Bellevue Life Sciences Acquisition Corp. filed its 10-K on Mar 31, 2023 for the period ending Dec 31, 2022. In this report its auditor, WithumSmith+Brown, PC , gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.75 USD | 0.00% | 0.00% | +2.38% |
1st Jan change | Capi. | |
---|---|---|
+2.38% | 60.45M | |
+111.71% | 6.55B | |
+98.02% | 1.23B | |
+2.52% | 986M | |
+14.96% | 752M | |
+2.11% | 666M | |
+2.33% | 620M | |
-.--% | 600M | |
+8.61% | 528M | |
-.--% | 500M |
- Stock Market
- Equities
- BLAC Stock
- News Bellevue Life Sciences Acquisition Corp.
- Bellevue Life Sciences Acquisition Corp. Auditor Raises 'Going Concern' Doubt